Dermatologic Manifestations of Scabies
- Author: Kelly M Cordoro, MD; Chief Editor: Dirk M Elston, MD more...
Background
Human scabies is an intensely pruritic skin infestation caused by the host-specific mite, Sarcoptes scabiei var hominis. Scabies has been a source of human infestation for more than 2500 years, dating back to Roman times. Originally, the Romans used the term scabies to denote any pruritic skin disease. In the 17th century, Giovanni Cosimo Bonomo identified the mite as one cause of scabies. The name Sarcoptes scabiei is derived from the Greek words sarx (the flesh) and koptein (to smite or cut) and the Latin word scabere (to scratch).[1]
Today, the term scabies refers to the skin lesions produced by this mite. A readily treatable infestation, scabies remains common primarily because of diagnostic difficulty, inadequate treatment of patients and their contacts, and improper environmental control measures. Scabies is a great clinical imitator. Its spectrum of cutaneous manifestations and associated symptoms often results in delayed diagnosis. In fact, the phrase "7-year itch" was first used with reference to persistent, undiagnosed infestations with scabies.
Scabies is a worldwide public health problem, affecting persons of all ages, races, and socioeconomic groups. Overcrowding, delayed diagnosis and treatment, and poor public education contribute to the prevalence of scabies in both industrial and nonindustrial nations. Prevalence rates are higher in children and sexually active individuals than in other persons. Patients with poor sensory perception due to entities such as leprosy and persons with immunocompromise due to conditions such as status posttransplantation, HIV disease, and old age are at particular risk for the crusted variant. These populations present with clinically atypical lesions and often are misdiagnosed, thus delaying treatment and elevating the risk of local epidemics.
For a pediatric perspective, see the eMedicine article Scabies.
Pathophysiology
Human scabies is caused by the S scabiei mite, var hominis, an obligate human parasite and is shown in the image below.
Scabies mite scraped from a burrow (original magnification, 400X). Animal scabies mites may result in transient symptoms in humans, but they are not a cause of persistent infestations. The most efficient means of transmission is via direct and prolonged contact with an infected individual. Mites can survive up to 3 days away from human skin, so fomites such as infested bedding or clothing are an alternate but infrequent source of transmission.
The entire life cycle of the mite lasts 30 days and is spent within the human epidermis. After copulation, the male mite dies and the female mite burrows into the superficial skin layers and lays a total of 60-90 eggs. The ova require 10 days to progress through larval and nymph stages to become mature adult mites. Less than 10% of the eggs laid result in mature mites.
Mites move through the top layers of skin by secreting proteases that degrade the stratum corneum. They feed on dissolved tissue but do not ingest blood. Scybala (feces) are left behind as they travel through the epidermis, creating linear lesions clinically recognized as burrows.
An affected individual harbors a variable number of living mites, typically less than 100 and usually no more than 10-15. In immunocompromised hosts, the weak immune response fails to control the disease and results in a fulminant hyperinfestation termed crusted scabies. The number of mites in a patient with crusted scabies can exceed 1 million. In these cases, the mite can survive off the host for up to 7 days, feeding on the sloughed skin in the local environment such as bedsheets, clothing, and chair covers. Failure to implement environmental control measures in this situation may result in relapse and reinfestation after successful treatment of the host.
Certain patient populations are susceptible to crusted scabies. These include patients with primary immunodeficiency disorders or a compromised ability to mount an immune response secondary to drug therapy. A modified host response may be a key factor in patients with malnutrition. Motor nerve impairments result in the inability to scratch in response to the pruritus, thus disabling the utility of scratching to remove mites and destroy burrows. Rare cases immunocompetent patients developing the crusted variant without clear explanation have been described.
The incubation period prior to onset of symptoms depends on whether the infestation is an initial exposure or a relapse/reinfestation. Upon initial infestation, a delayed type IV hypersensitivity reaction to the mites, eggs, or scybala develops over the ensuing 4-6 weeks. Previously sensitized individuals can develop symptoms within hours of reexposure. The hypersensitivity reaction is responsible for the intense pruritus that is the clinical hallmark of the disease.
Epidemiology
Frequency
International
Approximately 300 million cases of scabies are reported worldwide each year. In developed countries, scabies epidemics occur primarily in institutional settings such as prisons and long-term care facilities such as nursing homes and hospitals.[2] Prevalence rates in developing countries are higher than those in developed nations. Natural disasters, war, and poverty lead to overcrowding and increased rates of transmission.
Mortality/Morbidity
Complications of scabies are rare and generally result from vigorous rubbing and scratching. Disruption of the skin barrier puts the patient at risk for secondary bacterial invasion, primarily by Streptococcus pyogenes and Staphylococcus aureus. Superinfection with S pyogenes can precipitate acute poststreptococcal glomerulonephritis and even rheumatic fever. More common pyodermas include impetigo and cellulitis, which may rarely result in sepsis. Scabies infestations can exacerbate underlying eczema, psoriasis, Grover disease, and other preexisting dermatoses. Even with appropriate treatment, scabies can leave in its wake residual eczematous dermatitis and/or postscabietic pruritus, which can be debilitating and recalcitrant.
Crusted scabies carries an increased mortality rate because of the frequency of secondary bacterial infections resulting in sepsis.
Race
No racial predilection has been proven for scabies.
Sex
No predilection is recognized for scabies.
Age
Classic scabies is more common in children and in people who are sexually active. Crusted scabies occurs predominantly in patients who are immunocompromised, elderly, institutionalized, or bedridden.
Haubrich WS. Medical Meanings: A Glossary of Word Origins. Philadelphia, Pa: American College of Physicians; 1997:200.
Makigami K, Ohtaki N, Ishii N, Yasumura S. Risk factors of scabies in psychiatric and long-term care hospitals: a nationwide mail-in survey in Japan. J Dermatol. Sep 2009;36(9):491-8. [Medline].
Mehta V, Balachandran C, Monga P, Rao R, Rao L. Images in clinical practice. Norwegian scabies presenting as erythroderma. Indian J Dermatol Venereol Leprol. Nov-Dec 2009;75(6):609-10. [Medline].
Hay RJ. Scabies and pyodermas--diagnosis and treatment. Dermatol Ther. Nov-Dec 2009;22(6):466-74. [Medline].
Svecova D, Chmurova N, Pallova A, Babal P. Norwegian scabies in immunosuppressed patient misdiagnosed as an adverse drug reaction. Epidemiol Mikrobiol Imunol. Aug 2009;58(3):121-3. [Medline].
Phan A, Dalle S, Balme B, Thomas L. Scabies with clinical features and positive darier sign mimicking mastocytosis. Pediatr Dermatol. May-Jun 2009;26(3):363-4. [Medline].
Bezold G, Lange M, Schiener R, et al. Hidden scabies: diagnosis by polymerase chain reaction. Br J Dermatol. Mar 2001;144(3):614-8. [Medline].
Johnston G, Sladden M. Scabies: diagnosis and treatment. BMJ. Sep 17 2005;331(7517):619-22. [Medline].
Karthikeyan K. Treatment of scabies: newer perspectives. Postgrad Med J. Jan 2005;81(951):7-11. [Medline].
[Guideline] British Association for Sexual Health and HIV (BASHH). United Kingdom national guideline on the management of scabies infestation. National Guideline Clearinghouse. Feb 15 2008.
Aubin F, Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med. Mar 2 1995;332(9):612. [Medline].
Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis. Jan-Mar 1998;2(3):152-4. [Medline].
Elgart GW, Meinking TL. Ivermectin. Dermatol Clin. Apr 2003;21(2):277-82. [Medline].
Lin S, Farber J, Lado L. A case report of crusted scabies with methicillin-resistant Staphylococcus aureus bacteremia. J Am Geriatr Soc. Sep 2009;57(9):1713-4. [Medline].
Brodell RT, Helms SE. Bedside testing: the diagnostic cornerstone of dermatology. Compr Ther. Mar 1997;23(3):211-7. [Medline].
Burgess I. Sarcoptes scabiei and scabies. Adv Parasitol. 1994;33:235-92. [Medline].
Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Cutis. Apr 2000;65(4):233-40. [Medline].
Fitzpatrick TB, Austen KF, Wolff K, et al, eds. Dertmatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:1812-3.
Elgart ML. Scabies. Dermatol Clin. Apr 1990;8(2):253-63. [Medline].
Fitzpatrick TB, Johnson RA, Wolff K. Inset Bites and Infestations. In: Fitzpatrick TJ, Johnson RA, Wolff K, Polano MK, Suurmond R, eds. Color Atlas and Synopsis of Clinical Dermatology. 3rd ed. New York, NY: McGraw-Hill; 1997:836-61.
Guldbakke KK, Khachemoune A. Crusted scabies: a clinical review. J Drugs Dermatol. Mar 2006;5(3):221-7. [Medline].
McCarthy JS, Kemp DJ, Walton SF, Currie BJ. Scabies: more than just an irritation. Postgrad Med J. Jul 2004;80(945):382-7. [Medline].
Molinaro MJ, Schwartz RA, Janniger CK. Scabies. Cutis. Dec 1995;56(6):317-21. [Medline].
Orkin M, Maibach HI. Scabies treatment: current considerations. Curr Probl Dermatol. 1996;24:151-6. [Medline].
Paller AS. Scabies in infants and small children. Semin Dermatol. Mar 1993;12(1):3-8. [Medline].
Schleicher SM, Stewart P. Scabies: the mite that roars. Emerg Med. 1997;6:54-8.
Print
